베타
임상 레이더 AI
임상시험 NCT07249762은(는) 패혈증, 화상 부상, 상처 치유, 중증 질환, Multiple Organ Dysfunction Syndrome에 대해 대상자모집전 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요.
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰

Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1 40

대상자모집전
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '임상시험 설명'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT07249762은(는) 패혈증, 화상 부상, 상처 치유, 중증 질환, Multiple Organ Dysfunction Syndrome에 대해 알아보는 관찰연구입니다. 현재 상태는 대상자모집전이며, 2026년 5월 15일부터 참여 신청이 가능합니다. 40명의 참여자를 모집할 예정입니다. Henry M. Jackson Foundation for the Advancement of Military Medicine이(가) 진행하는 이 연구는 2027년 12월 15일까지 진행될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2026년 2월 4일에 갱신되었습니다.
간단한 개요
This study is following adult patients with serious burn injuries to better understand how their bodies respond to treatment and recovery. Researchers will collect small amounts of blood and tissue samples, along with information already recorded in the medical record, such as vital signs, lab results, and details of surgeries or complications. The goal is to identify patterns that may help predict who is at higher r...더 보기
상세한 설명
This is a prospective observational study of adult patients with significant burn injuries. The purpose is to understand the body responses to significant burns, treatment, and recovery and to identify factors that predict complications like infection or sepsis. By studying patterns in clinical information, blood, and tissue samples to develop computer-based models intended to improve diagnosis and guide future treat...더 보기
공식 제목

Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1

질환명
패혈증화상 부상상처 치유중증 질환Multiple Organ Dysfunction Syndrome
출판물
이 임상시험에 대해 발표된 과학 논문 및 연구 자료.
기타 연구 식별자
  • USUHS.2025-153
  • HT94252320022 (기타 보조금/자금 번호) (Congressionally Directed Medical Research Programs)
NCT 번호
실제 연구 시작일
2026-05-15
최신 업데이트 게시
2026-02-04
예상 연구 완료일
2027-12-15
계획된 등록 인원
40
연구종류
관찰연구
상태
대상자모집전
키워드
Burn Infection
Sepsis
Critical Illness
Thermal Injury
Infection
Multiple Organ Dysfunction Syndrome (MODS)
Acute Respiratory Distress Syndrome (ARDS)
Wound Healing
Biomarkers
Digital Twin Model
Predictive Analytics
Surgical Critical Care
시험군 / 개입
참가자 그룹/시험군개입/치료
Group 1 - Minimal Risk Burn Patient
The study includes adult patients (18 years and older) admitted with significant burn injuries involving more than 10% of their total body surface area (TBSA) who require surgical management and/or care within a surgical critical care setting. As part of their participation, small amounts of blood are collected at scheduled times during hospitalization, and small pieces of skin or tissue normally removed during burn ...더 보기
Observational Cohort (No Intervention)
This is not a treatment trial-no drugs, devices, or procedures are being tested. Participants receive standard burn care only. The research involves collecting blood and tissue samples (when clinically indicated) and reviewing medical record data.
주요결과변수
결과변수측정값 설명시간 범위
Incidence of Sepsis and Other Major Complications After Burn Injury
Clinical data will be collected from medical records to capture whether patients develop sepsis, organ dysfunction, or other serious complications following burn injury.
During hospitalization, up to 12 months after discharge
참여 도우미
적격성 기준

연령대
성인, 노인
최소 연령
18 Years
참여 가능한 성별
전체
  • Burn Injury >10% TBSA with who have a recognized concurrent or impending risk for clinical decompensation.
  • Male and female ages 18 years and older (maximum age of 80 years old) with burn injury or related illness requiring surgical care or treatment in a critical care or emergency setting who are being cared for at an SC2i-member clinical care facility (Emory/Grady, USF and USAISR) will be considered for study.
  • Ability to understand the purposes and risks of the study and to provide informed consent, either through written documentation or in accordance with the IRB-approved Waiver of Documentation of Consent procedures. In the case of incapacitated patients, a willing Legally Authorized Representative (LAR) may provide informed consent in accordance with written documentation or under the provisions of the approved Waiver of Documentation of Consent.

  • Any condition that, in the opinion of the attending physician, would place the patient or volunteer subject at undue risk by participating. Specific conditions include but are not limited to anemia prohibitive of phlebotomy, or technical considerations that would prevent acquisition of sufficient tissue for clinical use.
  • Pregnant patients
  • Minors < 18 years of age
  • Prisoners
Henry M. Jackson Foundation for the Advancement of Military Medicine logoHenry M. Jackson Foundation for the Advancement of Military Medicine
연구 대표 연락처
연락처: Seth Schobel-McHugh, PhD, (301) 295-3164, [email protected]
3 1개국에 임상시험 장소

Florida

University of South Florida - Tampa General Hospital, Tampa, Florida, 33606, United States
Jared Troy, MD, 연락처, 832-496-1567, [email protected]

Georgia

Emory University-Grady Memorial Hospital, Atlanta, Georgia, 30303, United States
Laura Pruskowski, MD, 연락처, 404) 616 - 9852, [email protected]

Texas

United States Army Institute of Surgical Research, Houston, Texas, 78234, United States
Kaitlin Pruskowski, PharmD, 연락처, 210-438-7024, [email protected]